Clinical Trials
2 trialsNCT00265798 2026-04-28
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT01091207 2012-01-20
Sorafenib for Imatinib/Sunitinib-failed GIST
Samsung Medical Center
Phase 2 Completed